Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Rybkarybka Rybkarybka Merchant
Aug 5, 2021 $82.33 -18.96% $101.59 X 81.04% 0
Aug 4, 2021 $85.60 -3.01% $88.26 X 96.99% 1
JS JS Pro
Aug 4, 2021 $87.89 -0.42% $88.26 X 99.58% 5
Rybkarybka Rybkarybka Merchant
Aug 4, 2021 $91.17 +3.30% $88.26 X 96.70% 1
Jul 30, 2021 $100.30 +44.25% $69.53 X 55.75% 1
JS JS Pro
Jul 16, 2021 $87.85 +9.69% $80.09 X 90.31% 0
JS JS Pro
Jun 15, 2021 $72.57 +0.65% $72.10 X 99.35% 4
Jun 15, 2021 Bullish $72.10 X 0
JS JS Pro
Jun 7, 2021 $63.41 -6.18% $67.59 X 93.82% 0
Jun 7, 2021 Bullish $67.59 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE